Rheumatoid Arthritis (RA) Clinical Trials

54 recruiting

Frequently Asked Questions

Common questions about Rheumatoid Arthritis (RA) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 57 trials

Recruiting
Not Applicable

Plant-Based Diet for Patients With Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Center for Clinical Research and Prevention180 enrolled2 locationsNCT07268326
Recruiting

Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+2 more
Cairo University460 enrolled1 locationNCT07277491
Recruiting
Phase 1

A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA).

Rheumatoid Arthritis (RA)
Kali Therapeutics, Inc.24 enrolled1 locationNCT07234773
Recruiting
Phase 2

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

COVID-19Inflammatory Bowel DiseaseRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre660 enrolled3 locationsNCT06599658
Recruiting

Dysphagia in Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Tanta University137 enrolled2 locationsNCT07401732
Recruiting

A RWS of SC MTX in Chinese RA Patients

Rheumatoid Arthritis (RA)
Peking University People's Hospital10,000 enrolled1 locationNCT07463937
Recruiting

Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Astellas Pharma Inc3,000 enrolled47 locationsNCT03971253
Recruiting
Phase 1Phase 2

A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)
Novartis Pharmaceuticals27 enrolled10 locationsNCT07048197
Recruiting
Not Applicable

HiSCs in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Shanghai Changzheng Hospital15 enrolled1 locationNCT06947746
Recruiting
Not Applicable

Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT

Rheumatoid Arthritis (RA)
Kasr El Aini Hospital75 enrolled1 locationNCT07438652
Recruiting
Phase 2

Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Toll Biotech Co. Ltd. (Beijing)24 enrolled6 locationsNCT07408024
Recruiting
Not Applicable

At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]

Rheumatoid Arthritis (RA)
SecondWave Systems Inc.60 enrolled5 locationsNCT07163221
Recruiting

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Multiple SclerosisRheumatoid Arthritis (RA)Dermatomyositis+4 more
Kyverna Therapeutics70 enrolled1 locationNCT07403188
Recruiting
Phase 2

Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Surf Therapeutics40 enrolled2 locationsNCT07293871
Recruiting
Not Applicable

Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being

Rheumatoid Arthritis (RA)
Weill Medical College of Cornell University250 enrolled1 locationNCT07222696
Recruiting
Phase 1

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

HealthyRheumatoid Arthritis (RA)
Eli Lilly and Company134 enrolled9 locationsNCT07258849
Recruiting
Phase 1

An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology28 enrolled1 locationNCT06946199
Recruiting
Early Phase 1

Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07347860
Recruiting
Phase 1

A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Philogen S.p.A.42 enrolled2 locationsNCT07245992
Recruiting

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Rheumatoid Arthritis (RA)Atherosclerotic Cardiovascular Disease (ASCVD)
Brigham and Women's Hospital120 enrolled1 locationNCT07315997